ImmunologybioRxiv
Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients
C. Kreer, M. Zehner, T. Weber…·F. Klein
This study isolates potent SARS-CoV-2-neutralizing antibodies from COVID-19 patients as early as 8 days post-diagnosis and identifies precursor B cells in healthy individuals.
DOI 10.1016/j.cell.2020.06.044